Exploring RWD in Australia & New Zealand
In Episode 2 of our Health Data Passport Series, we journey to Australia and New Zealand to discover their robust Real World Data assets, including unique longitudinal prescription (LRx) and...
Tag: IQVIA
Data Modernization: How Federal Agencies Are Learning from Commercial Peers
Across federal agencies, diverse legacy approaches to data management, data interoperability, and data sharing have taken shape over decades, making it increasingly challenging to maximize the value of data even...
Expanding Opportunities to Leverage Real-World Data
Non-profit patient organizations and medical specialty societies provide valuable real-world data that can facilitate academic research, educate through publications, and provide patient insights. This data can be leveraged to provide...
Advancing Precision Oncology Research through Real-World Evidence (RWE): Current Landscape and Future Challenges in the European Context
The theme of this webinar focuses on exploring the current state of the Oncology European Real-World Evidence (RWE) landscape and how IQVIA is contributing to advancements in cancer research in...
The role of Real World Evidence in Precision Oncology
The promise of precision medicine – using information about an individual’s genetic profile and other characteristics to inform clinical management – has fuelled a rapid rise in new innovative targeted...
Why Healthcare Organizations Can Benefit from New Sources of Real-World Data
Acquiring Data Blog Series: Part 1 The Data You Have Is Only A Beginning Many not-for-profit healthcare organizations already manage valuable data about the patients or providers they serve. Today...
The FDA Is Opening the Use of Registry Data in Drug Development – What Does It Mean for Patient Advocacy Groups?
FDA’s draft guidances on real-world data do not provide strict requirements for industry stakeholders to abide by, but they offer patient advocacy organizations with a clearer understanding of how to...
Unlock the Keys to Effective Real World Data Usage
RWD can deepen our understanding of patient journeys, reveal important treatment pathways, and demonstrate drug safety and efficacy under complex circumstances. But how much do you know about the standards...
From Real World Data to Real World Evidence: Growth and Impact of OMOP CDM
Join IQVIA experts as they explore the impact of the Observational Health Data Sciences & Informatics (OHDSI) network in key clinical studies and regulatory decisions, and how IQVIA’s partnership has...
Mood disorders and Real-World Evidence: Supporting drug development and improving patient outcomes
Importance of recognizing mental health 10th October is World Mental Health Day; this year’s campaign is centred around “Making Mental Health & Well-Being for All a Global Priority”. Throughout this blog,...